RIM - regulatory information management
•
0 likes•545 views
The document describes a regulatory software system that: 1. Manages regulatory activities and tracks progress for product registrations across countries. 2. Produces regulatory summaries and creates tasks for registration and lifecycle management activities. 3. Generates alerts when tasks are late and tracks agency correspondence.
Report
Share
Report
Share
Download to read offline
Recommended
Why is Regulatory Information Management (RIM) Important?
How can you be you are compliant with all regulations when there are so many to manage? Learn how leading life sciences companies are using new processes, as well as new technologies to create tailor-made solutions, enabling global strategies in regulatory operations in this complimentary on-demand webinar: http://ap.pn/2eLrMAP
Regulatory Information Management - Everybody deserves the Truth
Learn why RIM is becoming software no.1 to life science companies and how cune-RIM can help you with increasing number of requirements from regulatory authorities, increasing submission complexity and burden, increasing costs and inefficient work. You grew out of spreadsheets long time ago - it's now time for Regulatory Information Management (RIM)! Watch our webinar recording here: https://cunesoft.com/en/downloads/webinar-library/ or visit cune-RIM page directly: https://cunesoft.com/en/products/rim/
Your next RIM solution - 3 key considerations for your move
Considering to move to a new Regulatory Information Management system? Have a look at our pick of the 3 key considerations while moving to a new RIM system.
If you wish to receive more information - write us at info@cunesoft.com or visit our page https://cunesoft.com/en/products/rim/
The IDMP Challenge - Whitepaper on ISO IDMP by Cunesoft
The updated whitepaper on ISO IDMP - learn what you need to know during this transition. And how Cunesoft's cune-IDMP can help your organization: https://cunesoft.com/en/products/idmp/
Quality assurance audits in pharma industries
Quality audits are systematic examinations to determine if activities comply with plans and regulations. Pharmaceutical manufacturers use audits to verify compliance with Good Manufacturing Practices (GMP). Audits have two goals - to verify manufacturing systems are controlled and to permit timely problem correction. Audits evaluate GMP compliance in production and quality control. They are performed routinely and in cases like recalls. Areas audited include personnel, facilities, equipment, production, quality control, documentation, and more. Audits are classified as internal, external, or regulatory. Internal audits ensure quality systems and identify pre-inspection problems. External audits reduce risk for partners. Regulatory audits build cooperation between authorities. Effective auditing requires qualified staff, documentation,
ISO IDMP: Practical considerations from XEVMPD experience
ISO IDMP (Identification of Medicinal Products) is coming! What lessons can we learn from our practical exprience with XEVMPD in preparation for IDMP? Topics include data cleaning, managing inconsistencies across product registrations and countries and controlled vocabularies
Data integrity & ALCOA+
Data integrity is critical throughout the CGMP data life cycle, including in the creation, modification, processing, maintenance, archival, retrieval, transmission, and disposition of data after the record’s retention period ends. It would be helpful for data management.
Marketing Authorization procedures & premarket requirements sea countries
This document provides an overview of marketing authorization procedures and premarketing requirements for drug product registration in Southeast Asian countries. It discusses the regulatory framework in the ASEAN region and details the marketing authorization processes in major Southeast Asian countries like Singapore, Malaysia, Thailand, Indonesia, and the Philippines. The key steps involved are application submission, evaluation, and the regulatory decision. Requirements like dossier format, samples, certificates, and administrative documents are also summarized. Finally, some regulatory challenges around GMP compliance, labeling requirements, authorization timelines, and country-specific rules are highlighted.
Recommended
Why is Regulatory Information Management (RIM) Important?
How can you be you are compliant with all regulations when there are so many to manage? Learn how leading life sciences companies are using new processes, as well as new technologies to create tailor-made solutions, enabling global strategies in regulatory operations in this complimentary on-demand webinar: http://ap.pn/2eLrMAP
Regulatory Information Management - Everybody deserves the Truth
Learn why RIM is becoming software no.1 to life science companies and how cune-RIM can help you with increasing number of requirements from regulatory authorities, increasing submission complexity and burden, increasing costs and inefficient work. You grew out of spreadsheets long time ago - it's now time for Regulatory Information Management (RIM)! Watch our webinar recording here: https://cunesoft.com/en/downloads/webinar-library/ or visit cune-RIM page directly: https://cunesoft.com/en/products/rim/
Your next RIM solution - 3 key considerations for your move
Considering to move to a new Regulatory Information Management system? Have a look at our pick of the 3 key considerations while moving to a new RIM system.
If you wish to receive more information - write us at info@cunesoft.com or visit our page https://cunesoft.com/en/products/rim/
The IDMP Challenge - Whitepaper on ISO IDMP by Cunesoft
The updated whitepaper on ISO IDMP - learn what you need to know during this transition. And how Cunesoft's cune-IDMP can help your organization: https://cunesoft.com/en/products/idmp/
Quality assurance audits in pharma industries
Quality audits are systematic examinations to determine if activities comply with plans and regulations. Pharmaceutical manufacturers use audits to verify compliance with Good Manufacturing Practices (GMP). Audits have two goals - to verify manufacturing systems are controlled and to permit timely problem correction. Audits evaluate GMP compliance in production and quality control. They are performed routinely and in cases like recalls. Areas audited include personnel, facilities, equipment, production, quality control, documentation, and more. Audits are classified as internal, external, or regulatory. Internal audits ensure quality systems and identify pre-inspection problems. External audits reduce risk for partners. Regulatory audits build cooperation between authorities. Effective auditing requires qualified staff, documentation,
ISO IDMP: Practical considerations from XEVMPD experience
ISO IDMP (Identification of Medicinal Products) is coming! What lessons can we learn from our practical exprience with XEVMPD in preparation for IDMP? Topics include data cleaning, managing inconsistencies across product registrations and countries and controlled vocabularies
Data integrity & ALCOA+
Data integrity is critical throughout the CGMP data life cycle, including in the creation, modification, processing, maintenance, archival, retrieval, transmission, and disposition of data after the record’s retention period ends. It would be helpful for data management.
Marketing Authorization procedures & premarket requirements sea countries
This document provides an overview of marketing authorization procedures and premarketing requirements for drug product registration in Southeast Asian countries. It discusses the regulatory framework in the ASEAN region and details the marketing authorization processes in major Southeast Asian countries like Singapore, Malaysia, Thailand, Indonesia, and the Philippines. The key steps involved are application submission, evaluation, and the regulatory decision. Requirements like dossier format, samples, certificates, and administrative documents are also summarized. Finally, some regulatory challenges around GMP compliance, labeling requirements, authorization timelines, and country-specific rules are highlighted.
Regulatory intelligence
The document discusses regulatory intelligence and its importance. It defines regulatory intelligence as gathering and analyzing publicly available regulatory information, communicating implications, and monitoring regulations for opportunities. Sources of information discussed include regulatory authority websites, agency meeting minutes, previous drug approvals, and social media. Regulatory intelligence is used by pharmaceutical companies for product planning, regulatory agencies to consider precedents, and lawyers to interpret laws. The document encourages sharing knowledge and regulatory intelligence methods.
IDMP and RIM: friend or foe?
1) IDMP and RIM aim to harmonize product and regulatory information management but face challenges due to conflicting data sources and definitions between organizations and regions.
2) Implementing IDMP requires mapping diverse internal data systems and formats to a common IDMP data model and identifiers, which is complicated by varying data quality, timeliness, and ownership.
3) A master data management approach is needed to define authoritative sources, ownership, validation requirements, and change control to accurately populate the IDMP data containers and address issues across multiple systems over time.
Regulatory Information Management
This is the agenda and brochure for Pharma IQ's upcoming Regulatory Information Management conference on the 2nd and 3rd of March in London.
This conference is the only event of its kind to focus solely on the management of information within pharmaceutical companies, to aid regulatory submissions. The event will bring together leading professionals to focus on the regulatory aspects of data and information management.
The Electronic Regulatory Submission
The document discusses the electronic common technical document (eCTD) format for regulatory submissions to agencies like the FDA. It describes the structure of an eCTD, which includes five modules containing administrative information, summaries, quality details, nonclinical studies, and clinical studies. It also discusses the process of developing and submitting an eCTD, including using XML and PDF files. Regulatory agencies in countries like the US, EU, Japan and Canada accept eCTD submissions for applications like new drug applications.
Electronic Common Technical Document (eCTD)
This document provides an overview of the electronic Common Technical Document (eCTD) format used for regulatory drug submissions. It discusses the history and goals of the ICH and eCTD, the components and structure of an eCTD, best practices for preparing documents, and software options. Key points covered include the folder structure, use of XML and metadata, concept of reuse and granularity, and comparing the benefits of eCTD to traditional paper submissions. The conclusion emphasizes that adopting eCTD is essential to joining the electronic bandwagon, while also needing intermediate steps to fully transition from paper CTD formats.
eCTD Submissions
Disclaimer:
I have created this document with inputs from various sources. Some are taken right from slideshare. I just try to make this topic little compact and lucid, so that everybody can understand it easily
I am very much thankful to the original authors also, don't think I am just doing plagarism.
EU Variations & Renewals
The document provides information on variations and renewals of marketing authorizations in the European Union. It discusses the different types of variations (Type IA, IB, II and extensions), including examples. It describes the classification guidelines and regulations governing variations in the EU. It also outlines the documentation requirements, timelines and procedures for notification and approval of variations. Finally, it discusses marketing authorization renewals in the EU, noting they must be applied for at least 9 months before expiration for the authorization to remain valid indefinitely.
EU POST-APPROVAL CHANGES
Type 1A and 1B variations are minor variations that have minimal or no impact on safety, efficacy, or quality. Type 1A variations are further divided into those requiring immediate notification ("IAIN") and those not requiring it ("IA"). Type II variations are major variations that may significantly impact safety, efficacy, or quality. Extensions apply to changes like new strengths or forms and require full evaluation. Variations are submitted based on classification and some can be grouped together in a single submission. The process involves regulatory submission and approval timelines that differ based on variation type. Marketing authorizations must be renewed every 5 years upon application by the holder to remain valid indefinitely.
Computer System Validation
This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.
Several approaches to software validation exist and may be appropriate for a specific project.
The scope of any validation effort depends upon a number of factors
Size and complexity of the software,
Origin of the software (custom vs. off-the-shelf) and
Whether the functions are critical or non-critical in nature.
By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements.
US FDA post approval changes
The document discusses post-approval changes that can be made to approved NDAs and ANDAs. It describes four reporting categories for post-approval changes based on their potential impact: major changes requiring prior approval, moderate changes reported via a CBE-30 or CBE-0 supplement, minor changes reported annually. Examples are provided for different types of changes that fall under each reporting category. The levels of reporting ensure that manufacturers can make certain changes while providing appropriate notification to the FDA depending on the level of change.
ANVISA regulatory authority of brazil
ANVISA is the regulatory body for health surveillance in Brazil. It was established in 1999 to protect public health by regulating products and services under health surveillance. ANVISA's mission is to protect and promote health by ensuring hygiene, safety of products and services, and facilitating access. The agency is responsible for surveillance of areas like drugs, cosmetics, food, medical devices, and more. It coordinates the National Health Surveillance System and establishes standards. ANVISA's website provides information on regulations, registered products, permits and more.
ICH Q7 Guideline
The document discusses ICH Q7, a guideline for good manufacturing practices for active pharmaceutical ingredients. It aims to improve quality, enhance productivity and effectiveness of API manufacturing. ICH Q7 applies to APIs made through chemical synthesis, extraction, fermentation or combinations and establishes requirements for quality management, personnel, facilities, equipment, documentation, materials management, production controls, packaging and more. Adherence to ICH Q7 helps ensure APIs are safe, effective and of good quality and prepared according to cGMP standards expected by regulatory agencies like the FDA.
Electronic Submissions
Electronic submissions allow companies to submit regulatory applications like NDAs, BLAs, and INDs to agencies electronically instead of via paper. The eCTD format is now the preferred standard, organized into folders with an XML backbone and PDF files. Key benefits of electronic submissions include faster review times, elimination of duplicate documents, improved records management and archiving. While challenges remain, the future is a fully electronic environment across all FDA divisions to increase efficiency.
Manufacturing Documentation
Document is any written statement or proof.
It is not just routine procedure it has its basic objective of supplying information when required.
Regulatory Strategy In Emerging Markets
PAREXEL Principal Consultant Angela McGillivary discusses commercial considerations, clinical development, regulatory requirements, submission and post approval strategies in emerging markets
Regulatory Intelligence
Regulatory intelligence involves acquiring knowledge through analyzing various internal and external information sources to enable timely, data-driven decision making in the complex and evolving global regulatory landscape. A regulatory intelligence platform can integrate internal quality and compliance data with external sources like FDA reports, clinical studies, and regulations. This provides a holistic view to identify risks, prioritize improvements, and help maintain market advantage. However, many organizations still struggle with data access, analysis, and using analytics to impact business outcomes. Assessing internal audit and complaint data alongside external benchmarks can help evaluate inspection readiness and prioritize compliance issues.
Post marketing surveillance
This document discusses post-marketing surveillance (PMS), which involves monitoring drugs after they reach the market to detect previously unrecognized effects. PMS is important for safety and improving products. Key goals are identifying adverse effects and characterizing incidence rates. Several methods are used in PMS, including voluntary reporting, controlled trials, cohort studies, and case-control studies. Cohort studies follow groups over time to assess outcomes, while case-control studies compare exposure rates between those with and without a disease. PMS provides real-world evidence on drug performance and benefits patients.
EU Pharmacovigilance legislation
TIMELINE
PHARMACOVIGILANCE STAKEHOLDERS
ERMS – RECOMMENDATIONS 2005 – KEY CHANGES
2006 CONSULTATIONS – 2008 PROPOSALS
NEW DIRECTIVE 2010/84/EU
PHARMACOVIGILANCE
New regulation (EC) No 726/2004
PHARMACOVIGILANCE OF HUMAN MPs
PHARMACOVIGILANCE OF VETERINARY MPS
MILESTONES 2011-2012
REGULATION (EU) 520/2012
ICH GUIDELINES
GPvP GUIDELINES
MILESTONES – FURTHER DEVELOPMENT
New EU Requirements for Qualification & Validation
This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II. It is a GMP requirement that manufacturers control the critical aspects of their particular operations through qualification and validation over the life cycle of the product and process. Any planned changes to the facilities, equipment, utilities and processes, which may affect the quality of the product, should be formally documented and the impact on the validated status or control strategy assessed. Computerised systems used for the manufacture of medicinal products should also be validated according to the requirements of Annex 11. The relevant concepts and guidance presented in ICH Q8, Q9, Q10 and Q11 should also be taken into account.
Highlights of the guidance are given in following presentation.
eTMF ppt
An eTMF is an electronic system for organizing and storing documents related to clinical trials. It replaces paper regulatory binders with electronic storage in a computer server or cloud. Key benefits include increased compliance, efficiency, transparency, and cost savings compared to paper-based systems. While adoption of eTMFs is growing, challenges remain around scope, performance for large document volumes, and change management for training users.
Introduction to DevOps
This presentation will explain the meaning of the term DevOps, why is it required, the current practices & description of each of these practices, a DevOps pipeline & relation to micro-services.
How eCTD Software Simplifies Compliance of Submission & Publishing Process?
Simplifying compliance in the submission and publishing process is crucial for successful regulatory outcomes.
Visit Us :- https://www.aquilasolutions.us/
More Related Content
What's hot
Regulatory intelligence
The document discusses regulatory intelligence and its importance. It defines regulatory intelligence as gathering and analyzing publicly available regulatory information, communicating implications, and monitoring regulations for opportunities. Sources of information discussed include regulatory authority websites, agency meeting minutes, previous drug approvals, and social media. Regulatory intelligence is used by pharmaceutical companies for product planning, regulatory agencies to consider precedents, and lawyers to interpret laws. The document encourages sharing knowledge and regulatory intelligence methods.
IDMP and RIM: friend or foe?
1) IDMP and RIM aim to harmonize product and regulatory information management but face challenges due to conflicting data sources and definitions between organizations and regions.
2) Implementing IDMP requires mapping diverse internal data systems and formats to a common IDMP data model and identifiers, which is complicated by varying data quality, timeliness, and ownership.
3) A master data management approach is needed to define authoritative sources, ownership, validation requirements, and change control to accurately populate the IDMP data containers and address issues across multiple systems over time.
Regulatory Information Management
This is the agenda and brochure for Pharma IQ's upcoming Regulatory Information Management conference on the 2nd and 3rd of March in London.
This conference is the only event of its kind to focus solely on the management of information within pharmaceutical companies, to aid regulatory submissions. The event will bring together leading professionals to focus on the regulatory aspects of data and information management.
The Electronic Regulatory Submission
The document discusses the electronic common technical document (eCTD) format for regulatory submissions to agencies like the FDA. It describes the structure of an eCTD, which includes five modules containing administrative information, summaries, quality details, nonclinical studies, and clinical studies. It also discusses the process of developing and submitting an eCTD, including using XML and PDF files. Regulatory agencies in countries like the US, EU, Japan and Canada accept eCTD submissions for applications like new drug applications.
Electronic Common Technical Document (eCTD)
This document provides an overview of the electronic Common Technical Document (eCTD) format used for regulatory drug submissions. It discusses the history and goals of the ICH and eCTD, the components and structure of an eCTD, best practices for preparing documents, and software options. Key points covered include the folder structure, use of XML and metadata, concept of reuse and granularity, and comparing the benefits of eCTD to traditional paper submissions. The conclusion emphasizes that adopting eCTD is essential to joining the electronic bandwagon, while also needing intermediate steps to fully transition from paper CTD formats.
eCTD Submissions
Disclaimer:
I have created this document with inputs from various sources. Some are taken right from slideshare. I just try to make this topic little compact and lucid, so that everybody can understand it easily
I am very much thankful to the original authors also, don't think I am just doing plagarism.
EU Variations & Renewals
The document provides information on variations and renewals of marketing authorizations in the European Union. It discusses the different types of variations (Type IA, IB, II and extensions), including examples. It describes the classification guidelines and regulations governing variations in the EU. It also outlines the documentation requirements, timelines and procedures for notification and approval of variations. Finally, it discusses marketing authorization renewals in the EU, noting they must be applied for at least 9 months before expiration for the authorization to remain valid indefinitely.
EU POST-APPROVAL CHANGES
Type 1A and 1B variations are minor variations that have minimal or no impact on safety, efficacy, or quality. Type 1A variations are further divided into those requiring immediate notification ("IAIN") and those not requiring it ("IA"). Type II variations are major variations that may significantly impact safety, efficacy, or quality. Extensions apply to changes like new strengths or forms and require full evaluation. Variations are submitted based on classification and some can be grouped together in a single submission. The process involves regulatory submission and approval timelines that differ based on variation type. Marketing authorizations must be renewed every 5 years upon application by the holder to remain valid indefinitely.
Computer System Validation
This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.
Several approaches to software validation exist and may be appropriate for a specific project.
The scope of any validation effort depends upon a number of factors
Size and complexity of the software,
Origin of the software (custom vs. off-the-shelf) and
Whether the functions are critical or non-critical in nature.
By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements.
US FDA post approval changes
The document discusses post-approval changes that can be made to approved NDAs and ANDAs. It describes four reporting categories for post-approval changes based on their potential impact: major changes requiring prior approval, moderate changes reported via a CBE-30 or CBE-0 supplement, minor changes reported annually. Examples are provided for different types of changes that fall under each reporting category. The levels of reporting ensure that manufacturers can make certain changes while providing appropriate notification to the FDA depending on the level of change.
ANVISA regulatory authority of brazil
ANVISA is the regulatory body for health surveillance in Brazil. It was established in 1999 to protect public health by regulating products and services under health surveillance. ANVISA's mission is to protect and promote health by ensuring hygiene, safety of products and services, and facilitating access. The agency is responsible for surveillance of areas like drugs, cosmetics, food, medical devices, and more. It coordinates the National Health Surveillance System and establishes standards. ANVISA's website provides information on regulations, registered products, permits and more.
ICH Q7 Guideline
The document discusses ICH Q7, a guideline for good manufacturing practices for active pharmaceutical ingredients. It aims to improve quality, enhance productivity and effectiveness of API manufacturing. ICH Q7 applies to APIs made through chemical synthesis, extraction, fermentation or combinations and establishes requirements for quality management, personnel, facilities, equipment, documentation, materials management, production controls, packaging and more. Adherence to ICH Q7 helps ensure APIs are safe, effective and of good quality and prepared according to cGMP standards expected by regulatory agencies like the FDA.
Electronic Submissions
Electronic submissions allow companies to submit regulatory applications like NDAs, BLAs, and INDs to agencies electronically instead of via paper. The eCTD format is now the preferred standard, organized into folders with an XML backbone and PDF files. Key benefits of electronic submissions include faster review times, elimination of duplicate documents, improved records management and archiving. While challenges remain, the future is a fully electronic environment across all FDA divisions to increase efficiency.
Manufacturing Documentation
Document is any written statement or proof.
It is not just routine procedure it has its basic objective of supplying information when required.
Regulatory Strategy In Emerging Markets
PAREXEL Principal Consultant Angela McGillivary discusses commercial considerations, clinical development, regulatory requirements, submission and post approval strategies in emerging markets
Regulatory Intelligence
Regulatory intelligence involves acquiring knowledge through analyzing various internal and external information sources to enable timely, data-driven decision making in the complex and evolving global regulatory landscape. A regulatory intelligence platform can integrate internal quality and compliance data with external sources like FDA reports, clinical studies, and regulations. This provides a holistic view to identify risks, prioritize improvements, and help maintain market advantage. However, many organizations still struggle with data access, analysis, and using analytics to impact business outcomes. Assessing internal audit and complaint data alongside external benchmarks can help evaluate inspection readiness and prioritize compliance issues.
Post marketing surveillance
This document discusses post-marketing surveillance (PMS), which involves monitoring drugs after they reach the market to detect previously unrecognized effects. PMS is important for safety and improving products. Key goals are identifying adverse effects and characterizing incidence rates. Several methods are used in PMS, including voluntary reporting, controlled trials, cohort studies, and case-control studies. Cohort studies follow groups over time to assess outcomes, while case-control studies compare exposure rates between those with and without a disease. PMS provides real-world evidence on drug performance and benefits patients.
EU Pharmacovigilance legislation
TIMELINE
PHARMACOVIGILANCE STAKEHOLDERS
ERMS – RECOMMENDATIONS 2005 – KEY CHANGES
2006 CONSULTATIONS – 2008 PROPOSALS
NEW DIRECTIVE 2010/84/EU
PHARMACOVIGILANCE
New regulation (EC) No 726/2004
PHARMACOVIGILANCE OF HUMAN MPs
PHARMACOVIGILANCE OF VETERINARY MPS
MILESTONES 2011-2012
REGULATION (EU) 520/2012
ICH GUIDELINES
GPvP GUIDELINES
MILESTONES – FURTHER DEVELOPMENT
New EU Requirements for Qualification & Validation
This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II. It is a GMP requirement that manufacturers control the critical aspects of their particular operations through qualification and validation over the life cycle of the product and process. Any planned changes to the facilities, equipment, utilities and processes, which may affect the quality of the product, should be formally documented and the impact on the validated status or control strategy assessed. Computerised systems used for the manufacture of medicinal products should also be validated according to the requirements of Annex 11. The relevant concepts and guidance presented in ICH Q8, Q9, Q10 and Q11 should also be taken into account.
Highlights of the guidance are given in following presentation.
eTMF ppt
An eTMF is an electronic system for organizing and storing documents related to clinical trials. It replaces paper regulatory binders with electronic storage in a computer server or cloud. Key benefits include increased compliance, efficiency, transparency, and cost savings compared to paper-based systems. While adoption of eTMFs is growing, challenges remain around scope, performance for large document volumes, and change management for training users.
What's hot (20)
New EU Requirements for Qualification & Validation
New EU Requirements for Qualification & Validation
Similar to RIM - regulatory information management
Introduction to DevOps
This presentation will explain the meaning of the term DevOps, why is it required, the current practices & description of each of these practices, a DevOps pipeline & relation to micro-services.
How eCTD Software Simplifies Compliance of Submission & Publishing Process?
Simplifying compliance in the submission and publishing process is crucial for successful regulatory outcomes.
Visit Us :- https://www.aquilasolutions.us/
Compliance Management System
In today's rapidly evolving business landscape, staying compliant with an ever-increasing number of regulations and industry standards is paramount. This is where cloud-based Compliance Management System come into play. A cloud-based compliance management system is a powerful tool that enables organisations to efficiently and effectively manage their compliance requirements while harnessing the benefits of cloud technology. Unlike traditional Compliance Management System that rely on on-premises infrastructure, cloud-based systems leverage the scalability, flexibility, and accessibility of cloud computing. These systems provide a centralised platform where businesses can monitor, track, and ensure adherence to various regulations and standards, all within a secure and user-friendly digital environment.
Compliance Management System
Staying compliant with an ever-increasing number of rules and industry standards is critical in today's fast-changing corporate world. The cloud-based Compliance Management System comes into play here. A cloud-based compliance management system is a powerful tool that helps enterprises to manage their compliance needs easily and effectively while reaping the benefits of cloud technology. Unlike traditional Compliance Management Systems that rely on on-premises infrastructure, cloud-based systems make use of cloud computing's scalability, flexibility, and accessibility. These systems provide a centralised platform for enterprises to monitor, track, and assure compliance with numerous regulations and standards, all while operating in a safe and user-friendly digital environment.
Vendor Compliance Management software
Vendor Compliance Management software has become an essential tool for businesses, enabling them to effectively manage vendors and ensure adherence to laws, regulations, and industry standards. In today's intricate supply chain landscape, organizations must possess an efficient and dependable method for vendor management. This software automates vendor onboarding, monitors vendor performance, handles contracts and audits, and facilitates due diligence. By leveraging such software, businesses can save time, minimize manual efforts, and enhance compliance in their vendor management workflows. In this article, we will explore the primary advantages of Vendor Compliance Management software and its role in streamlining vendor management processes for organizations.
MainManager Specifications
The document provides an overview of MainManager, a facilities management software solution. MainManager allows users to manage maintenance tasks, assets, budgets, and other facility operations through an online platform. It provides features like helpdesk management, task scheduling, cost tracking, and reporting. The software aims to simplify facilities management processes, improve cost control and transparency, and allow remote access to key information for various stakeholders like owners, finance directors, facility managers, and contractors.
Kiran_CV
Kiran Kumar has over 7 years of experience in system administration and software testing. He has worked on projects involving taxation software, workflow management, and CRM systems for clients like Supreme Industries and Adaequare Info Pvt Ltd. His skills include system administration, test case design, functional testing, regression testing, and automation testing using tools like HP QTP and QC. He has expertise in SQL, VBScript, and testing concepts like the SDLC and STLC.
Case Study : Prison Audit Tool for Large Government Institution
Successive Software created an audit instrument that helps the compliance managers to manage each facility and the practices within the prescribed framework. Successive Software helped the institution to develop the technology behind the audit instrument and implemented the same on the client servers.
Compliance Software For Proactive Compliance Management | ComplyGlobal
ComplyGlobal is a cloud-based global compliance management software to manage your risks proactively. Contact us to streamline your compliance management. They have many type of solutions software available such as hr compliance software, regulatory compliance software, payroll compliance software, and many more. You can visit the website for more information: http://www.complyglobal.com/
Locus why locus_platform
Locus Platform is a cloud-based software that helps organizations manage their environmental, health, safety, and compliance information. It offers:
- Tools to organize tasks, permits, monitoring data, incidents, emissions, waste, audits, and sustainability initiatives in one system.
- Configurable forms, reports, workflows, and notifications to track requirements and automate processes.
- Mobile access to forms and reports for offline use.
- Customization options through its configuration toolbox to build customized applications.
- Reliable support from an experienced team to ensure successful implementation and use of the system.
ARC 4.1 Flyer
This document describes an audit and compliance management software called ARC that helps skilled nursing facilities achieve complete compliance with CMS regulations. It contains over 40 audit modules covering all regulatory areas. The software facilitates auditing, committee review of results, and corrective action tracking. It provides templates and automatically generates documents. Using ARC can significantly reduce facilities' costs and risks of fines while optimizing revenue.
DevOps & Blockchain: Powering Rapid Software Delivery in Regulated Environments
As IT organizations push forward with DevOps tools that automate application development and maintenance processes, they can lose sight of the key “who, what, where and when” variables that surround software releases, thus elevating the possibility of noncompliance with a host of regulatory mandates. By embracing blockchain, they can create a tamper-proof way of ensuring regulatory compliance while extending their embrace of IT service automation.
Labour Law Compliance
Simpliance is a cloud-based platform that provides all the tools and resources needed to manage compliance in a single, unified system. It consolidates and automatically updates all relevant laws and allows users to schedule recurring compliances. Simpliance reduces compliance costs by up to 70% and provides real-time dashboards and alerts to monitor compliance status. The platform also includes tools for evidence management, customizable checklists, audit management, and reporting.
Labour Law Compliance
Single Repository for Labour Law Compliance, Minimum Wages, Notifications, Forms, Acts, Rules and Labour Law Consultants
Comply Global
ComplyGlobal is a cloud-based global compliance management software to manage your risks proactively. Contact us to streamline your compliance management. You can visit our site on http://www.complyglobal.com/
Comply Global
ComplyGlobal is a cloud-based global compliance management software to manage your risks proactively. Contact us to streamline your compliance management.
Maintaining Continuous Compliance with HCL BigFix
The rise in security threats affecting endpoints and the changing landscape of mobile and cloud-driven work environments has created new challenges for IT teams. BigFix Compliance offers a unified endpoint management solution that provides real-time visibility and policy enforcement to safeguard complex and widely distributed IT environments. It significantly reduces the administrative burden of compliance reporting and ensures adherence to standards, helping organizations protect their endpoints and minimize attack surfaces with minimal effort.
How QEdge assist you to accelerate your ROI?
QEdge provide you a single unified platform to streamline and automate your process, people, procedure and documentation for better transparency, control and performance.
How Does Compliance Management Software Help Compliance Managers
With an ever-increasing amount of compliance standards, manually organizing and tracking compliance operations is time-consuming and error-prone. This is where compliance management software may help. This software enables compliance managers to streamline company procedures, improve productivity, and sustain an up-front approach to compliance by employing modern technology capabilities.
For more details: https://bit.ly/3LDxYIt
BigFix Inventory
BigFix Inventory Identifies licensed and unlicensed software with drill-down granularity to pass more audits, limit security exposures, and reduce annual software expenditures. Besides reducing the time, effort, and inaccuracy of manual inventory and analysis, it also manages hundreds—or hundreds of thousands—of Microsoft Windows, UNIX, Linux, and macOS endpoint assets. It inventories all endpoints, whether on-premise or in the cloud, and integrates with other asset management tools such as ServiceNow and IBM Control Desk.
Similar to RIM - regulatory information management (20)
How eCTD Software Simplifies Compliance of Submission & Publishing Process?
How eCTD Software Simplifies Compliance of Submission & Publishing Process?
Case Study : Prison Audit Tool for Large Government Institution
Case Study : Prison Audit Tool for Large Government Institution
Compliance Software For Proactive Compliance Management | ComplyGlobal
Compliance Software For Proactive Compliance Management | ComplyGlobal
DevOps & Blockchain: Powering Rapid Software Delivery in Regulated Environments
DevOps & Blockchain: Powering Rapid Software Delivery in Regulated Environments
How Does Compliance Management Software Help Compliance Managers
How Does Compliance Management Software Help Compliance Managers
Recently uploaded
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recently uploaded (20)
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
RIM - regulatory information management
- 1. Plans regulatory activities & tracks progress for all registrations and products across all countries and regions. Produces electronic regulatory product intelligence that provides current, comprehensive regulatory summaries. Creates regulatory tasks starting with new registrations through to lifecycle management activities. Enables affiliate engagement and allows for task delegation to other team members. Generates alerts when tasks are not finished within agreed timeframes and indicates which are potentially adding risk to submission timelines. Tracks and archives authority correspondence for all submissions and products within one integrated regulatory content management system. Manages post-marketing registration activities that are required and allows for the creation of submission backbones with eCTD module. Publishes helpful reports with real-time information on the status of registrations, upcoming renewals and agency interactions in various countries and across products. Reports can be generated using a variety of filters from XEVMPD and IDMP criteria. Facilitates setting and tracking of KPIs related to regulatory projects. Better compliance Improved efficiencies Global availability xEVMPD and IDMP-ready Advantages: About Cunesoft: We offer a ready to use, pre-validated and highly secure cloud based regulatory compliance suite. Our software has been built to fulfill regulatory needs holistically and end to end. Our vision is to keep it as simple as possible while delivering compliance and fulfilling FDA 21CFR11, EU Annex 11, ICH, and GxP requirements. Cunesoft, Inc. Princeton, NJ Phone: +1 (609) 955 3468 Cunesoft GmbH Munich, Germany Phone: +49 (089) 235 14741 www.cunesoft.com